PP
FBIO icon

Paloma Partners’s Fortress Biotech FBIO Stock Holding History

Paloma Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,940
Closed -$246K – 2049
2019
Q2 		$246K Buy
+10,940
New +$281K ﹤0.01% 1413
2014
Q3 		– Sell
-9,882
Closed -$255K – 1105
2014
Q2 		$255K Buy
+9,882
New +$261K 0.01% 854

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Paloma Partners's FBIO Position: Q3 2019 in Review

Paloma Partners sold out of Fortress Biotech (FBIO) in Q3 2019, closing a stake of 10,940 shares — an estimated $246K sold.

Paloma Partners first reported a position in FBIO in Q2 2014 and held it in 2 quarters. The position peaked at $255K in Q2 2014. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

  • Paloma Partners reported no remaining Fortress Biotech position as of Q3 2019 after selling out during the quarter.
  • Paloma Partners sold 10,940 Fortress Biotech shares in Q3 2019, an estimated $246K.
  • Paloma Partners first reported a position in Fortress Biotech in Q2 2014 and held it in 2 quarters.
  • Paloma Partners's Fortress Biotech position peaked at $255K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.